Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy Stock

Showing results (51-60 of 322) with videos related to

Pageof 33
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 5, 2022
Hispanic ethnicity and the rs4880 variant in SOD2 are associated with elevated liver enzymes and bilirubin levels in children receiving asparaginase-containing chemotherapy for acute lymphoblastic leukemiaSharon Wu, Mengxi Wang, Amani Alqahtani, et al.
Blood|May 25, 2004
Irreversible myelosuppression after fludarabine-melphalan conditioning: observations in patients with graft rejectionKoen Van Besien, Sonali Smith, John Anastasi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2008
Paucity of HLA-identical unrelated donors for African-Americans with hematologic malignancies: the need for new donor optionsAlexander Dew, Demetria Collins, Andrew Artz, et al.
Leukemia Research|May 30, 2006
A Phase II study of Bcl-2 antisense (oblimersen sodium) combined with gemtuzumab ozogamicin in older patients with acute myeloid leukemia in first relapseJoseph Moore, Karen Seiter, Jonathan Kolitz, et al.
Seminars in Oncology|March 23, 2011
Gene mutations, epigenetic dysregulation, and personalized therapy in myeloid neoplasia: are we there yet?Olatoyosi Odenike, Michael J Thirman, Andrew S Artz, et al.
Cancer|January 27, 2010
Adult acute lymphoblastic leukemia: concepts and strategiesStefan Faderl, Susan O'Brien, Ching-Hon Pui, et al.
Seminars in Oncology Nursing|July 27, 2015
Inclusion of Adolescents and Young Adults in Cancer Clinical TrialsAaron R Weiss, Brandon Hayes-Lattin, Matthew A Kutny, et al.
Blood Advances|September 2, 2021
Racial and ethnic enrollment disparities and demographic reporting requirements in acute leukemia clinical trialsAndrew Hantel, Marlise R Luskin, Jacqueline S Garcia, et al.
International Journal of Oncology|April 6, 2006
Quantitative real-time RT-PCR monitoring of BCR-ABL in chronic myelogenous leukemia shows lack of agreement in blood and bone marrow samplesWendy Stock, Daohai Yu, Ted Karrison, et al.
Cancer|September 14, 2016
Adoption of pediatric-inspired acute lymphoblastic leukemia regimens by adult oncologists treating adolescents and young adults: A population-based studyLori Muffly, Daphne Lichtensztajn, Parveen Shiraz, et al.
Pageof 33

Showing results (51-60 of 322) with videos related to

Sort By:
Pageof 33
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 5, 2022
Hispanic ethnicity and the rs4880 variant in SOD2 are associated with elevated liver enzymes and bilirubin levels in children receiving asparaginase-containing chemotherapy for acute lymphoblastic leukemiaSharon Wu, Mengxi Wang, Amani Alqahtani, et al.
Blood|May 25, 2004
Irreversible myelosuppression after fludarabine-melphalan conditioning: observations in patients with graft rejectionKoen Van Besien, Sonali Smith, John Anastasi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2008
Paucity of HLA-identical unrelated donors for African-Americans with hematologic malignancies: the need for new donor optionsAlexander Dew, Demetria Collins, Andrew Artz, et al.
Leukemia Research|May 30, 2006
A Phase II study of Bcl-2 antisense (oblimersen sodium) combined with gemtuzumab ozogamicin in older patients with acute myeloid leukemia in first relapseJoseph Moore, Karen Seiter, Jonathan Kolitz, et al.
Seminars in Oncology|March 23, 2011
Gene mutations, epigenetic dysregulation, and personalized therapy in myeloid neoplasia: are we there yet?Olatoyosi Odenike, Michael J Thirman, Andrew S Artz, et al.
Cancer|January 27, 2010
Adult acute lymphoblastic leukemia: concepts and strategiesStefan Faderl, Susan O'Brien, Ching-Hon Pui, et al.
Seminars in Oncology Nursing|July 27, 2015
Inclusion of Adolescents and Young Adults in Cancer Clinical TrialsAaron R Weiss, Brandon Hayes-Lattin, Matthew A Kutny, et al.
Blood Advances|September 2, 2021
Racial and ethnic enrollment disparities and demographic reporting requirements in acute leukemia clinical trialsAndrew Hantel, Marlise R Luskin, Jacqueline S Garcia, et al.
International Journal of Oncology|April 6, 2006
Quantitative real-time RT-PCR monitoring of BCR-ABL in chronic myelogenous leukemia shows lack of agreement in blood and bone marrow samplesWendy Stock, Daohai Yu, Ted Karrison, et al.
Cancer|September 14, 2016
Adoption of pediatric-inspired acute lymphoblastic leukemia regimens by adult oncologists treating adolescents and young adults: A population-based studyLori Muffly, Daphne Lichtensztajn, Parveen Shiraz, et al.
Pageof 33